These are the top 10 stock to buy in July, according to Axis Securities

Current Price: ₹288

Target Price: ₹318

Implied gains in the next one year: 9.4%

Axis securities maintain a bullish outlook on MNDA’s ability to comprehensively beat industry performance by leveraging the broader vehicular trends of industry like EV, premiumization, automation. Its strategic inorganic acquisition will enhance product offering and gain market share. Its deep-rooted relationship with OEM’s will also increase its kit value, according to Axis Securities analysts.

Current Price: ₹206.85

Target Price: ₹230

Implied gains in the next one year: 10%

ITC’s healthy cash balance of ₹300 billion would enable it to sail through challenging times posed by COVID-19 outbreak. Post-COVID, the progressive normalization of operations across segments, share gain possibilities in the core cigarette business, quicker recovery in FMCG sales given increased in-home consumption and consumers’ preference towards trusted brands could support a quicker recovery in earnings.

Current Price: ₹583.10

Target Price: ₹650

Implied gains in the next one year: 10.2%

Regulatory challenges are well known, and Bharti Airtel is well-capitalized to deal with the payouts as it has raised enough capital (₹450 billion equity in FY20) and has access to debt as there are no major business solvency risks associated with it, the report cited.

Current Price: ₹397.20

Target Price: ₹474

Implied gains in the next one year: 16.2%

The Biocon’s contract research segment (Syngene) is expected to post revenue growth in low teens while the branded formulations business is expected to grow at low single-digit driven by additional capacity and entry into newer markets. It has also received the USFDA’s approval for its Insulin Glargine (Semglee) which paves the way for the launch in the US market currently controlled by Eli Lily and Sanofi.

Current Price: ₹943

Target Price: ₹1088

Implied gains in the next one year: 13.3%

According to analysts, MindTree’s Management initiated strong cost control measures like reducing the subcontractors, better service mix and higher execution will help to gain long term sustainable operating margins.

Current Price: ₹578.45

Target Price: ₹653

Implied gains in the next one year: 11.4%

Recent deal trends continue to be healthy for HCL tech and are reflective of traction in retail and Consumer packaged goods, manufacturing and BFSI verticals. HCL Tech has received various digital transformational deals worth more than $2.4bn in the quarter ended December. Axis Securities believes that COVID outbreak will create a huge opportunity across geographies for HCL Tech to post strong organic growth over different verticals.